bill odonnell
比尔odonnell
以上为机器翻译结果，长、整句建议使用 人工翻译 。
Schering-Plough maintains that Claritins patent should be extended because the company was unfairly affected by an unexpectedly long Food and Drug Administration review, according to Bill ODonnell, a spokesman for the company.
FORBES: Schering-Plough Stands to Lose Claritin Patent
应用推荐
模块上移
模块下移
不移动